Neurotrophic Keratopathy Treatment Landscape Set For Rapid Expansion By 2034, Says Delveinsight
Several companies, including ReGenTree, MimeTech, Oculis, and others are actively advancing treatments in the Neurotrophic Keratopathy market. < ...
Pharmaceutical Technology11 天
H-1337 by D. Western Therapeutics Institute for Open-Angle Glaucoma: Likelihood of Approval
H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.
Frontiers1 个月
Impact of galectin-3 on neurotrophic factor expression by PCR array: potential implications ...
Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, United States Corneal nerve regeneration is significantly influenced by the synergistic ...
Medscape3 年
Graefe's archive for clinical and experimental ophthalmology
Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database. Optical coherence tomography-measured retinal nerve fiber ...